Maryland HB1426 regulates clinical research pharmacies and clinical trials, including permit requirements and ownership rules.
Maryland HB1426 establishes regulations for clinical research pharmacies and clinical trials. It mandates that a clinical research pharmacy permit is required to operate in the state. The permit is issued by the Board of Pharmacy and must be held by each individual operating a clinical research pharmacy. The bill also allows a health care provider to hold an ownership interest in a clinical research pharmacy under specific conditions.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.